Geneos Wealth Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.2K | Sell |
984
-984
| -50% | -$6.2K | ﹤0.01% | 2504 |
|
|
2025
Q1 | $12.6K | Buy |
1,968
+984
| +100% | +$6.31K | ﹤0.01% | 2497 |
|
|
2024
Q4 | $7.91K | Hold |
984
| – | – | ﹤0.01% | 2149 |
|
|
2024
Q3 | $12.4K | Hold |
984
| – | – | ﹤0.01% | 1753 |
|
|
2024
Q2 | $12.5K | Hold |
984
| – | – | ﹤0.01% | 1490 |
|
|
2024
Q1 | $4.7K | Hold |
984
| – | – | ﹤0.01% | 1718 |
|
|
2023
Q4 | $4.72K | Hold |
984
| – | – | ﹤0.01% | 1733 |
|
|
2023
Q3 | $7.12K | Sell |
984
-250
| -20% | -$1.81K | ﹤0.01% | 1651 |
|
|
2023
Q2 | $9.17K | Hold |
1,234
| – | – | ﹤0.01% | 1597 |
|
|
2023
Q1 | $8.55K | Hold |
1,234
| – | – | ﹤0.01% | 1589 |
|
|
2022
Q4 | $12.7K | Hold |
1,234
| – | – | ﹤0.01% | 1466 |
|
|
2022
Q3 | $22K | Sell |
1,234
-836
| -40% | -$14.9K | ﹤0.01% | 1292 |
|
|
2022
Q2 | $118K | Buy |
2,070
+261
| +14% | +$14.9K | 0.01% | 951 |
|
|
2022
Q1 | $133K | Buy |
1,809
+1,004
| +125% | +$73.8K | 0.01% | 971 |
|
|
2021
Q4 | $115K | Buy |
805
+425
| +112% | +$60.7K | ﹤0.01% | 1109 |
|
|
2021
Q3 | $69K | Hold |
380
| – | – | ﹤0.01% | 1338 |
|
|
2021
Q2 | $82K | Sell |
380
-204
| -35% | -$44K | ﹤0.01% | 1245 |
|
|
2021
Q1 | $138K | Buy |
584
+254
| +77% | +$60K | ﹤0.01% | 1150 |
|
|
2020
Q4 | $23K | Buy |
330
+230
| +230% | +$16K | ﹤0.01% | 1824 |
|
|
2020
Q3 | $11K | Sell |
100
-575
| -85% | -$63.3K | ﹤0.01% | 1922 |
|
|
2020
Q2 | $52K | Sell |
675
-1,075
| -61% | -$82.8K | ﹤0.01% | 1198 |
|
|
2020
Q1 | $22K | Buy |
+1,750
| New | +$22K | ﹤0.01% | 1475 |
|
|
2019
Q4 | – | Sell |
-205
| Closed | -$1K | – | 2568 |
|
|
2019
Q3 | $1K | Hold |
205
| – | – | ﹤0.01% | 2423 |
|
|
2019
Q2 | $1K | Buy |
+205
| New | +$1K | ﹤0.01% | 2427 |
|